FDA Approves Afinitor A New Breast Cancer Drug

Afinitor / RxRecall / The Maher Law Firm

Afinitor (everolimus): On Friday July 20th 2012 the FDA approved a new drug in the fight against breast cancer. Afinitor (marketed by Novartis Pharmaceuticals Corp.) a drug that has been approved by the FDA to fight advanced kidney and neuroendocrine tumors, has now been approved by the FDA (Food and Drug Administration) to fight an [...]

Cancer-Drug Avastin on FDA Hot Seat

Breast Cancer Drug FDA Preview

Roche’s best-selling cancer drug, Avastin, is currently the subject of an unprecedented hearing set to take place this week. Federal regulators have scrutinized the once-promising drug after it proved to carry more risks than benefits in patients taking the medication as a treatment for breast cancer. In fact, the U.S. Food and Drug Administration granted [...]